Live Breaking News & Updates on Using Early Time Restricted Feeding

Type 2 diabetes is a chronic and progressive cardiometabolic disorder that affects more than 10% of adults worldwide and is a major cause of morbidity, mortality, disability, and high costs. Over the past decade, the pattern of management of diabetes has shifted from a predominantly glucose centric approach, focused on lowering levels of haemoglobin A1c (HbA1c), to a directed complications centric approach, aimed at preventing short term and long term complications of diabetes, and a pathogenesis centric approach, which looks at the underlying metabolic dysfunction of excess adiposity that both causes and complicates the management of diabetes. In this review, we discuss the latest advances in patient centred care for type 2 diabetes, focusing on drug and non-drug approaches to reducing the risks of complications of diabetes in adults. We also discuss the effects of social determinants of health on the management of diabetes, particularly as they affect the treatment of hyperglycaemia ....

United States , Diabetes Prevention Programme , American Diabetes Association Standards Of Care , Drug Administration , Action For Health , Australian Diabetes Society , Dietary Approaches , Stop Hypertension , Using Early Time Restricted Feeding , Timed Light Therapy , Improve Glycemic Control , Adults With Type , American Diabetes , European Association , Glycemia Reduction Approaches , Comparative Effectiveness , American Diabetes Association Standards , Evaluate Cardiovascular , Outcomes With Semaglutide , Subjects With Type , Research Study , How Semaglutide Compared , Placebo Affects Diabetic Eye Disease , People With Type ,